日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies

维奈托克治疗相关非核心结合因子急性髓系白血病的疗效

Senapati, Jayastu; Croden, Jennifer; Garcia-Manero, Guillermo; Takahashi, Koichi; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Short, Nicholas James; Jabbour, Elias; Haddad, Fadi; Marvin-Peek, Jennifer; Abbas, Hussein A; Bose, Prithviraj; Tang, Guilin; Loghavi, Sanam; Shpall, Elizabeth J; Ramdial, Jeremy; Popat, Uday R; Champlin, Richard E; Ravandi, Farhad; Kantarjian, Hagop M; Dinardo, Courtney D

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes

异基因造血干细胞移植对高危骨髓增生异常综合征患者的影响

Bazinet, Alexandre; Bataller, Alex; Chien, Kelly; Sasaki, Koji; Montalban-Bravo, Guillermo; Hammond, Danielle; Bouligny, Ian; Swaminathan, Mahesh; Jen, Wei Ying; Kugler, Eitan; Kanagal-Shamanna, Rashmi; Kadia, Tapan; Borthakur, Gautam; DiNardo, Courtney; Short, Nicholas; Pemmaraju, Naveen; Jabbour, Elias; Daver, Naval; Ravandi, Farhad; Urrutia, Samuel; Gener-Ricos, Georgina; Braish, Julie; Briski, Robert; Rodriguez-Sevilla, Juan Jose; Li, Ziyi; Champlin, Richard E; Shpall, Elizabeth J; Alousi, Amin; Oran, Betul; Hosing, Chitra; Ramdial, Jeremy L; Olson, Amanda; Pierce, Sherry; Chen, Julianne; Kantarjian, Hagop; Garcia-Manero, Guillermo; Popat, Uday

Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study

COMMANDS 研究中突变图谱和突变负荷对低危骨髓增生异常综合征 (LR-MDS) 患者红细胞输注反应的影响

Komrokji, Rami S; Hayati, Sheida; Ugidos, Manuel; Garcia-Manero, Guillermo; Della Porta, Matteo Giovanni; Zeidan, Amer M; Santini, Valeria; Platzbecker, Uwe; Gandhi, Anita K; Suragani, Rajasekhar N V S

Decitabine-cedazuridine in patients with MDS and TP53 mutations

地西他滨-西达扎瑞丁治疗伴有TP53突变的MDS患者

Urrutia, Samuel; Sasaki, Koji; Bataller, Alex; Kantarjian, Hagop; Montalban-Bravo, Guillermo; McCloskey, James; Griffiths, Elizabeth A; Yee, Karen; Zeidan, Amer; Savona, Michael; Oganesian, Aram; Sano, Yuri; Keer, Harold N; Garcia-Manero, Guillermo

Nanopatterned bioresorbable elastomeric scaffolds to promote neural, glial, and endothelial differentiation using human embryonic and induced pluripotent stem cells

利用纳米图案化生物可吸收弹性支架促进人胚胎干细胞和诱导多能干细胞向神经细胞、胶质细胞和内皮细胞分化

Romayor, Irene; Martín-Colomo, Sara; Polo, Yurena; Bello, Carlos; Basanta-Torres, Ruth; Manero-Roig, Irene; Pardo-Rodríguez, Beatriz; Luzuriaga, Jon; Unda, Fernando; Sarasua, Jose-Ramon; Ibarretxe, Gaskon; Larrañaga, Aitor; Eguizabal, Cristina; Pineda, Jose Ramon

DNA methyltransferase inhibitors in hematological malignancies and solid tumors

DNA甲基转移酶抑制剂在血液系统恶性肿瘤和实体瘤中的应用

Wenger, Valentin; Garcia-Manero, Guillermo; Zeiser, Robert; Lübbert, Michael

Transmission Ratio Distortion in Genetic Prion Diseases: Clarifying Methodological Considerations

遗传性朊病毒疾病的传播比率偏差:方法学考量澄清

Kortazar-Zubizarreta, Izaro; Manero-Azua, Africa; Eraña, Hasier; Castilla, Joaquín; Perez de Nanclares, Guiomar

A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies

微环境驱动机制决定了髓系恶性肿瘤的治疗反应和非突变依赖性治疗方法。

Ioanna Mosialou ,Abdullah M Ali ,Rossella Labella ,Brygida Bisikirska ,Alvaro Cuesta-Dominguez ,Paraskevi Vgenopoulou ,Ismarc Reyes ,Sanjana M Rao ,Anqi Wang ,Na Luo ,Marta Galan-Diez ,Junfei Zhao ,Brian J Chernak ,Jan Philipp Bewersdorf ,Kazuya Fukasawa ,Jiayu Su ,Jason Higa ,Rachel A Adams ,Adam L Corper ,Sergey Pampou ,Catherine M Woods ,Xiaomin Fan ,Roshan P Shah ,Julie Feldstein ,Na Liu ,Cui Liang ,Maël Heiblig ,Steven Kornblau ,Guillermo Garcia-Manero ,Ellin Berman ,Joseph G Jurcic ,Raul Rabadan ,Azra Raza ,Stavroula Kousteni

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes

骨髓增生异常综合征患者p53功能障碍的特征及临床意义

Zampini, Matteo; Riva, Elena; Lanino, Luca; Sauta, Elisabetta; Antunes Dos Reis, Rita; Ejarque, Rosa Maria Andres; Maggioni, Giulia; Termanini, Alberto; Merlotti, Alessandra; Campagna, Alessia; Dall'Olio, Lorenzo; Kulasekararaj, Austin; Calvi, Michela; Di Vito, Clara; Bonometti, Arturo; Rahal, Daoud; Croci, Giorgio; Boveri, Emanuela; Gianelli, Umberto; Ponzoni, Maurilio; Caselli, Rossella; Albertazzi, Serena; Todisco, Gabriele; Ubezio, Marta; Crisafulli, Laura; Frigo, Alessandro; Lugli, Enrico; Mosca, Ettore; Acha, Pamela; Ghisletti, Serena; Nicassio, Francesco; Santoro, Armando; Diez-Campelo, Maria; Solé, Francesc; Ades, Lionel; Platzbecker, Uwe; Santini, Valeria; Fenaux, Pierre; Haferlach, Torsten; Sallman, David; Garcia-Manero, Guillermo; Mavilio, Domenico; Remondini, Daniel; Castellani, Gastone; D'Amico, Saverio; Zeidan, Amer M; Komrokji, Rami; Kordasti, Shahram; Ficara, Francesca; Della Porta, Matteo Giovanni

Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML

对于不适合接受强化化疗的异柠檬酸脱氢酶突变型急性髓系白血病患者,一线三联疗法(包括去甲基化药物、维奈托克和异柠檬酸脱氢酶抑制剂)的疗效

DiNardo, Courtney D; Marvin-Peek, Jennifer; Loghavi, Sanam; Takahashi, Koichi; Issa, Ghayas C; Jen, Wei-Ying; Daver, Naval G; Reville, Patrick K; Short, Nicholas J; Sasaki, Koji; Mullin, Jillian K; Bradley, Corey A; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Abbas, Hussein A; Hammond, Danielle E; Haddad, Fadi; Bravo, Guillermo Montalban; Chien, Kelly S; Yilmaz, Musa; Kornblau, Steven M; Jabbour, Elias; Ravandi, Farhad; Kadia, Tapan; Garcia-Manero, Guillermo; Konopleva, Marina Y; Kantarjian, Hagop M